6/17
11:18 am
mrvi
Here's Why RGAIA Considers Maravai LifeSciences Holdings' (MRVI) Margin Structure as the Best [Yahoo! Finance]
Low
Report
Here's Why RGAIA Considers Maravai LifeSciences Holdings' (MRVI) Margin Structure as the Best [Yahoo! Finance]
6/11
09:52 pm
mrvi
RGA Investment Advisors - Maravai: Two Elite Assets With Other-Worldly Margins Wrapped In One [Seeking Alpha]
Low
Report
RGA Investment Advisors - Maravai: Two Elite Assets With Other-Worldly Margins Wrapped In One [Seeking Alpha]
5/28
05:11 pm
mrvi
MNMD, NBIX and OCUL are among after hour movers [Seeking Alpha]
High
Report
MNMD, NBIX and OCUL are among after hour movers [Seeking Alpha]
5/17
01:55 pm
mrvi
Maravai (MRVI) Advances in RNA Research With New Collaboration [Yahoo! Finance]
Low
Report
Maravai (MRVI) Advances in RNA Research With New Collaboration [Yahoo! Finance]
5/13
08:09 am
mrvi
TriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation Center [Yahoo! Finance]
Low
Report
TriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation Center [Yahoo! Finance]
5/13
08:00 am
mrvi
TriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation Center
Low
Report
TriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation Center
5/10
08:55 am
mrvi
Maravai LifeSciences Holdings First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]
Medium
Report
Maravai LifeSciences Holdings First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]
5/9
04:35 pm
mrvi
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Medium
Report
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
5/9
04:05 pm
mrvi
Maravai LifeSciences Announces May and June 2024 Investor Conference Schedule
Medium
Report
Maravai LifeSciences Announces May and June 2024 Investor Conference Schedule
5/9
08:17 am
mrvi
Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) had its price target raised by analysts at Robert W. Baird from $8.00 to $10.00. They now have an "outperform" rating on the stock.
Medium
Report
Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) had its price target raised by analysts at Robert W. Baird from $8.00 to $10.00. They now have an "outperform" rating on the stock.
5/9
03:27 am
mrvi
Maravai LifeSciences (MRVI) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Medium
Report
Maravai LifeSciences (MRVI) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
5/8
04:23 pm
mrvi
Maravai LifeSciences Reports First Quarter 2024 Financial Results [Yahoo! Finance]
High
Report
Maravai LifeSciences Reports First Quarter 2024 Financial Results [Yahoo! Finance]
5/8
04:05 pm
mrvi
Maravai LifeSciences Reports First Quarter 2024 Financial Results
High
Report
Maravai LifeSciences Reports First Quarter 2024 Financial Results
4/30
07:37 am
mrvi
TriLink BioTechnologies® and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology [Yahoo! Finance]
Low
Report
TriLink BioTechnologies® and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology [Yahoo! Finance]
4/30
07:31 am
mrvi
TriLink BioTechnologies® and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology
Medium
Report
TriLink BioTechnologies® and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology
4/18
07:44 am
mrvi
TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production [Yahoo! Finance]
Medium
Report
TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production [Yahoo! Finance]
4/18
07:36 am
mrvi
TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production
Medium
Report
TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production
4/10
04:05 pm
mrvi
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, May 8, 2024
Low
Report
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, May 8, 2024
4/10
08:17 am
mrvi
Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) is now covered by analysts at Craig Hallum. They set a "buy" rating and a $15.00 price target on the stock.
Low
Report
Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) is now covered by analysts at Craig Hallum. They set a "buy" rating and a $15.00 price target on the stock.